Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis - Poll - MDSpire

Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis

  • By

  • Liza M.Y. Gelissen

  • Stefan P.H. van den Berg

  • Alyssa A. Toorop

  • Martijn T. Wijburg

  • Emma C. Tallantyre

  • Ninotska I.L. Derksen

  • Floris C. Loeff

  • Joep Killestein

  • Theo Rispens

  • Zoé L.E. van Kempen

  • the NEXT-MS study group

  • May 8, 2026

  • 0 min

Share

Original Source(s)

Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis

  • by Liza M.Y. Gelissen, Stefan P.H. van den Berg, Alyssa A. Toorop, Martijn T. Wijburg, Emma C. Tallantyre, Ninotska I.L. Derksen, Floris C. Loeff, Joep Killestein, Theo Rispens, Zoé L.E. van Kempen, the NEXT-MS study group

  • May 8, 2026

Related Content

An Oxidative Glial Profile as a Predictor of Disability and Cognitive Decline in Primary Progressive Multiple Sclerosis

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Hippocampal neuronal hypoexcitability contributes to PTSD-like phenotypes in the experimental autoimmune encephalomyelitis model